DD120192A5 - - Google Patents

Info

Publication number
DD120192A5
DD120192A5 DD187639A DD18763975A DD120192A5 DD 120192 A5 DD120192 A5 DD 120192A5 DD 187639 A DD187639 A DD 187639A DD 18763975 A DD18763975 A DD 18763975A DD 120192 A5 DD120192 A5 DD 120192A5
Authority
DD
German Democratic Republic
Application number
DD187639A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD120192A5 publication Critical patent/DD120192A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
DD187639A 1974-08-05 1975-08-01 DD120192A5 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2438020A DE2438020A1 (de) 1974-08-05 1974-08-05 18-methyl-19-nor-20-keto-pregnane und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
DD120192A5 true DD120192A5 (en:Method) 1976-06-05

Family

ID=5922668

Family Applications (1)

Application Number Title Priority Date Filing Date
DD187639A DD120192A5 (en:Method) 1974-08-05 1975-08-01

Country Status (17)

Country Link
US (1) US4029777A (en:Method)
JP (1) JPS5141347A (en:Method)
AT (1) AT345998B (en:Method)
BE (1) BE832124A (en:Method)
CA (1) CA1037027A (en:Method)
CH (1) CH611910A5 (en:Method)
CS (2) CS175500B2 (en:Method)
DD (1) DD120192A5 (en:Method)
DE (1) DE2438020A1 (en:Method)
DK (1) DK136369C (en:Method)
ES (1) ES439720A1 (en:Method)
FR (1) FR2281123A1 (en:Method)
GB (1) GB1512258A (en:Method)
HU (1) HU171684B (en:Method)
IL (1) IL47770A (en:Method)
NL (1) NL7509326A (en:Method)
SE (1) SE404804B (en:Method)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61144199A (ja) * 1984-12-18 1986-07-01 Pioneer Electronic Corp スピ−カ用紙製振動部材の製造方法
EP0382790A4 (en) * 1987-08-25 1991-03-27 Kelvin W. Gee Compositions and methods for alleviating stress, anxiety and seizure activity
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
US5175154A (en) * 1987-11-25 1992-12-29 Research Corporation Technologies, Inc. 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds
SI2986623T1 (sl) 2013-04-17 2019-03-29 Sage Therapeutics, Inc. 19-NOR C3,3-disubstituirani C21-N-pirazolil steroidi in metode njhove uporabe
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
RS60420B1 (sr) 2013-04-17 2020-07-31 Sage Therapeutics Inc 19-nor neuroaktivni steroidi za metode lečenja
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
PT3021852T (pt) 2013-07-19 2021-04-21 Sage Therapeutics Inc Esteroides neuroativos, composições e utilizações das mesmas
JP6466942B2 (ja) 2013-08-23 2019-02-06 セージ セラピューティクス, インコーポレイテッド 向神経活性ステロイド、組成物、及びその使用
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
MX384728B (es) 2014-10-16 2025-03-14 Sage Therapeutics Inc Composiciones para el tratamiento de trastornos del snc.
LT3206493T (lt) 2014-10-16 2020-08-25 Sage Therapeutics, Inc. Kompozicijos ir būdai, skirti cns sutrikimams gydyti
HUE049014T2 (hu) 2014-11-27 2020-09-28 Sage Therapeutics Inc Készítmények és módszerek a központi idegrendszer rendellenességeinek kezelésére
WO2016123056A1 (en) 2015-01-26 2016-08-04 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
EP3258939B1 (en) 2015-02-20 2022-09-07 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
DK3481844T3 (da) 2016-07-11 2024-07-22 Sage Therapeutics Inc C7, C12 og C16 substituerede neuroaktive steroider og disses fremgangsmåder til anvendelse
IL264129B2 (en) 2016-07-11 2024-05-01 Sage Therapeutics Inc C20, C17 and C21 converted neuroactive steroids and methods of using them
EP4442695A3 (en) * 2017-12-22 2025-01-22 Sage Therapeutics, Inc. 19-homo, 3.alpha.-hydroxy-steroid-20-one compounds for treating cns disorders
EP3976628A1 (en) 2019-05-31 2022-04-06 Sage Therapeutics, Inc. Neuroactive steroids and compositions thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791196A (fr) * 1971-11-11 1973-05-10 Glaxo Lab Ltd Nouveaux steroides, leur procede de preparation et leurs applications
GB1409239A (en) * 1971-11-11 1975-10-08 Glaxo Lab Ltd Process for the preparation of 3alpha-hydroxy-5alpha-steroids

Also Published As

Publication number Publication date
DK136369B (da) 1977-10-03
HU171684B (hu) 1978-02-28
GB1512258A (en) 1978-05-24
IL47770A0 (en) 1975-10-15
ES439720A1 (es) 1977-03-01
AT345998B (de) 1978-10-10
CH611910A5 (en:Method) 1979-06-29
NL7509326A (nl) 1976-02-09
ATA600475A (de) 1978-02-15
DK136369C (da) 1978-02-27
CA1037027A (en) 1978-08-22
SE404804B (sv) 1978-10-30
SE7508777L (sv) 1976-02-06
DK344475A (da) 1976-02-06
IL47770A (en) 1978-10-31
CS175500B2 (en:Method) 1977-05-31
BE832124A (fr) 1976-02-05
FR2281123A1 (fr) 1976-03-05
JPS5141347A (en) 1976-04-07
US4029777A (en) 1977-06-14
AU8351575A (en) 1977-02-03
DE2438020A1 (de) 1976-02-26
CS175498B2 (en:Method) 1977-05-31

Similar Documents

Publication Publication Date Title
DK61875A (en:Method)
CS175498B2 (en:Method)
FR2259425A1 (en:Method)
FI752198A7 (en:Method)
FI751159A7 (en:Method)
FR2258849A1 (en:Method)
DK105375A (en:Method)
DK438974A (en:Method)
DK125475A (en:Method)
CS175058B1 (en:Method)
FI751564A7 (en:Method)
CS167175B1 (en:Method)
CH578866A5 (en:Method)
BG20244A1 (en:Method)
AU479931A (en:Method)
AU480264A (en:Method)
DD122481A5 (en:Method)
DD120844A5 (en:Method)
DD114932A1 (en:Method)
BG20217A1 (en:Method)
CH601523A5 (en:Method)
BG20001A1 (en:Method)
CH327274A4 (en:Method)
BG20473A1 (en:Method)
BG20457A1 (en:Method)